All Episodes
iasusa — 515 episodes
(June 9, 2026) IAS-USA Dialogue Series: Emerging Infections and Health Threats
1. Welcome and Introduction
2. Data to Decisions: The ART of Initial ART
5. Challenging Cases in Advanced HIV: Managing Opportunistic Infections and New Guidance on ART
6. Closing Remarks
3. Hepatitis B Dilemmas: Navigating HBV Risk in the Tenofovir-Sparing ART Era
4. Managing ARV Experienced Patients: I'd Rather Switch Than Fight!
(March 26, 2026) IAS-USA Dialogue Series: Emerging Infections and Health Threats
(HIV 2026 ATL) Key CROI 2026 Updates by Colleen F. Kelley, MD, MPH
(HIV 2026 ATL) STI Updates Current Trends in Treatment and Prevention by Jason E. Zucker, MD
(HIV 2026 ATL) Brain Health in Older Adults With HIV by Meredith Greene, MD
(HIV 2026 ATL) PrEP Updates New Long-Acting Injectables, Management Challenges, and Diagnostic Testing Dilemmas by ment Challenges, and Diagnostic Testing Dilemmas by Hyman Scott, MD, MPH
(HIV 2026 ATL) Cases in HIV Medicine Putting it all Together by Michael S. Saag, MD
(HIV 2026 ATL) Investigational Antiretroviral Drugs Injectables and Beyond by Rajesh T. Gandhi, MD
(HIV 2026 ATL) David Letterman as a Dermatologist Top 10 Skin Lesions You Should Know by Toby A. Maurer, MD
4. Updates on the Evolving Landscape of HIV Management in Pregnancy and Postpartum
9. SUDs in HIV Care: MOUD, Emerging Therapies, and PrEP in the Context of Stimulant Use
1. Welcome and Introductions
5. Key Updates From CROI 2026
7. Evolving Diabetes Care in PWH: Screening, Treatment, and the Rise of GLP-1 RA Therapies
6. Cases in the Clinic 2026: From Ragtime to Two Strangers
10. Immunizations for PWH: Efficacy, Safety, Evolving Recommendation
11. Closing Remarks
3. Optimizing Long-Acting Therapeutics in Practice: Real-World Considerations and Failure Management
8. Advances in HIV and STI Prevention: A 2026 Updat
2. Lifetime of Leadership Award Presented to Gerald H. Friedland, MD
RWCC Day 2: Rebecca Abelman - Hormones and Health The Menopausal Transition in Women With HIV
RWCC Day 2: Melanie Thompson - Screening for the Big Cs in HIV Care
RWWC Day 3: Henry Masur - HIV Associated OIs All Too Common Despite the Miraculous Advances in ART
RWWC Day 3: Welcome to Day 3
RWWC Day 3: Roy M. Gulick - Investigational Antiretroviral Drugs and Formulations
RWWC Day 3: Closing Remarks
RWWC Day 3: Sandra A Springer - Mastering the Clinical Triple Threat
RWCC Day 2: Caryn Morse - Aging With HIV Focus on Cognitive Impairment and Frailty
RWCC Day 2: Todd Brown - Metabolic Update 2025 Diabetes and CKM Syndrome
RWCC Day 1: Heather Hauck - HRSA Ryan White HIVAIDS Program Updates
RWCC Day 2: Michael Saag - Interactive ART Cases From the Clinic(ians) Case-Based Panel Discussion
RWCC Day 1: Khalil Ghanem - Preventing and Managing Syphilis in 2026
RWCC Day 1: Welcome and Introduction
RWCC Day 2: Roger Bedimo -No Mo FOMO
RWCC Day 2: Michael Saag - Welcome to Day 2
RWCC Day 1: Katharine J Bar - Update on the Cure From In Between Days to Just Like Heaven
RWWC Day 3: Christine M. Durand - HIV and Transplantation Practice and Possibilities
RWCC Day 2 Priscilla Y Hsue - 2025 Update on HIV and Cardiovascular Disease Lipids, Inflammation, and More
RWCC Day 1: Hyman Scott - Case-Based Approaches to Pre- and Postexposure Prophylaxis
“In Case You Missed It”: New Developments in HIV Prevention and Treatment
Closing Remarks
What Would You Do? Challenging Cases in HIV Management: Case-Based Panel Discussion
From DoxyPEP to Antimicrobial Resistance: The Changing Face of STIs
Be Prepared With PEP: Emergency Management of HIV, HBV, and HCV Exposures
Welcome and Introduction
HIV Vaccines in 2026 and Beyond: Promise and Persistence
Aging With HIV: How Not to Go Gently Into That Good Night
The Science of Aging: Epigenetics and Other Hallmarks of Aging
Immunization for Aging Adults With HIV: What’s New for the Old
Aging in the Context of HIV and Cancer: What Does “Age” Actually Mean?
Welcome and Introductions
Closing Remarks
HIV, Aging, and the Brain: A Practical Approach
From Fierce to Frail: Assessing Aging With HIV
Just Do It: Overcoming Clinical Inertia to Improve Heart Health
Update on the Cure: From In Between Days to Just Like Heaven
Closing Remarks
Beyond the Horizon: HIV Treatments in the Making
In Case You Missed It: Recent Changes in Guidelines, New Publications, & Updates
Aging with HIV: Optimizing Care for Older Adults
Welcome and Introduction
A Focused Update on Immunizations in People with HIV
Controversies in HIV Management: Case-Based Discussion
From Data to Action: Advances and Evolving Strategies in HIV and STI Prevention
(December 5, 2025) IAS-USA Dialogue Series: Emerging Infections and Health Threats
(August 13, 2025) Latest Update on Urgent Virus Outbreaks: Summer 2025
Chlamydia Management Updates: Advances and Vaccines Developments for STI Prevention
Latest Guidelines for Screening and Treatment for Human Papillomavirus and Anal Cancer
Welcome and Introduction
Preexposure Prophylaxis for HIV Infection: PrEP-Aring for The Next Decade
Preventing and Managing Syphilis in 2025
Updates on Hepatitis B Coinfection: Challenging Serology and Treatment Approaches
Drug-Resistant Gonorrhea: Epidemiology, Management, and Future Treatment
Closing Remarks
(May 13, 2025) Latest Update on Urgent Virus Outbreaks: Spring 2025
Ulcerative Sexually Transmitted Infections: Syphilis, Herpes Simplex Virus, Mpox, and Others
Updates on HIV Primary Care
Key Updates From CROI 2025
Year 13 of the Modern PrEP Era: A Spoon (Not a Fork) in the Road?
Weight Management and GLP-1 Receptor Agonists for People With HIV: Insights and Strategies
Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion
A Tough Nut to Crack? Update on Hepatitis B Cure
Next-Generation STI Prevention: DoxyPEP, CDC Guidelines, and the Gonorrhea Vaccine Debate
Treatment & Prevention of Syphilis in People With HIV, Addressing the Congenital Syphilis Epidemic
Anal Cancer Screening: Implementing Guidelines in the Real World
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Gender-Affirming Hormone Initiation and Antiretroviral Therapy Considerations
PrEP Update: Long-Acting Agents and PrEP During Pregnancy
Update on HIV Primary Care: New Data, New Guidelines
Closing Remarks
CROI 2025 Insights To Treat, Per Chance to Cure HIV
Welcome and Introduction
(January 15, 2025) Latest Update on Urgent Virus Outbreaks: Winter 2025
HIV Prevention and STI Prevention -- Lead: Raphael J. Landovitz, MD
Substance Use Disorder and HIV -- Lead: Sandra A. Springer, MD
Comorbidities in the Setting of ART: Focus on Cardiovascular Disease, Statins, and Weight Management -- Leads: Melanie A. Thompson, MD, and Roger J. Bedimo, MD
When and What to Start -- Lead: Huldrych F. Günthard, MD
Closing Remarks -- Co-Chairs: Rejesh T. Gandhi, MD, and Michael S. Saag, MD
Welcome and Introduction -- Co-Chairs: Rejesh T. Gandhi, MD, and Michael S. Saag, MD
Coinfections in the Setting of ART: Tuberculosis, Opportunistic Infections, and Others -- Lead: Brenda E. Crabtree Ramírez, MD
When and How to Switch -- Lead: Rajesh T. Gandhi, MD
Comprehensive Overview: Latest Guidelines for Screening and Treatment for Human Papillomavirus and Anal Cancer -- Presenter: Timothy J. Wilkin, MD, MPH
Closing -- Co-Chairs: Henry Masur, MD and Michael S. Saag, MD
Treating and Preventing HIV: Updates From the IAS–USA Guidelines -- Presenter: Rajesh T. Gandhi, MD
Advancements in Long-Acting Drugs for HIV Treatment and Prevention, Including Emerging Therapies -- Presenter: Roy M. Gulick, MD, MPH
A Pound of Cure: Exploring the Potential Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and Other Substance Use Treatments Beyond Opioids -- Presenter: Ellen F. Eaton, MD
Strategies to Reduce Cardiovascular Disease in Persons With HIV in 2024 – Where Do We Go From Here? -- Presenter: Priscilla Y. Hsue, MD
Welcome and Introductions -- Co-Chairs: Henry Masur, MD and Michael S. Saag, MD
Key Opportunistic Infections: Not Gone and Not Forgotten – Cases from the Clinic and Panel Discussion -- Presenter: Constance A. Benson, MD
Welcome (Day 2)
HIV and Aging: Focus on Neurocognitive Impairment -- Presenter: Meredith Greene, MD
Substance Use Disorder, HIV, and Mental Health -- Presenter: Karinn A. Glover, MD, MPH
Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion -- Presenter: Michael S. Saag, MD
Infections and Sexual Health – What’s New in Detection and Treatment: STI Updates From the Treatment Guidelines -- Presenter: Natalie Neu, MD, MPH
Diagnosis, Treatment, and Complications of Diabetes in People With HIV -- Presenter: Todd T. Brown, MD, PhD
Practice Changing Updates in the Primary Care Management of People With HIV -- Presenter: David H. Spach, MD
Comprehensive Review of Weight Loss Management -- Presenter: Zoobia W. Chaudhry, MBBS
From Cases to Care: Exploring Long-Acting HIV Therapies in Practice -- Presenter: Joshua P. Havens, PharmD
Top 10 Questions to the NCCC Warmline: What’s Coming Up for Providers Across the Country? -- Presenter: Carolyn Chu, MD, MSc
HIV Care: Successfully Navigating the Transition from Pediatric to Adult Care -- Presenter: Allison L. Agwu, MD, ScM
Shots, Shots, Shots: Updates on Oral and Injectable Preexposure Prophylaxis -- Presenter: Hyman Scott, MD, MPH
Welcome (Day 3)
New and Investigational Antiretroviral Drugs and Formulations: Transforming the Care of People with HIV -- Presenter: Rajesh T. Gandhi, MD
Patient Engagement in Care: Strategies to Inform Implementation Science and Practice -- Presenter: Michael J. Mugavero, MD, MHSc
‘Weighing’ the Clinical Benefits of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) -- Presenter: Suman Srinivasa, MD, MS
HRSA Ryan White HIV/AIDS Program Updates -- Presenter: Laura W. Cheever, MD, ScM
Treatment and Prevention of Syphilis in People With HIV -- Presenter: Kimberly A. Workowski, MD
Welcome and Introduction (Day 1)
Dermatologic Manifestations of HIV -- Presenter: Toby Maurer, MD
(October 4, 2024) Latest Update on Urgent Virus Outbreaks: October 2024
Cryptococcal Meningitis State Of The Art For Diagnosis, Treatment, And Prevention 1
No Brainers Think Again OIs In Brain, Lungs, And Elsewhere
Opportunistic Infections Past, Present, What's New, & Review Of Guidelines
Pneumocystis What’s Old And What’s New
Treatment And Diagnosis Of Mycobacterium Avium Complex Disease
Welcome And Introductions
Closing Remarks
(June 11) Latest Update on Urgent Virus Outbreaks: June 2024
Welcome and introductions
State of the ART: Hot Antiretroviral Updates from CROI 2024 and Beyond
“Weighing In” on GLP-1 Receptor Agonists for People With HIV
The Latest Updates on Immunizations for People With HIV
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Closing
Statins: Young at Heart
No Mo FOMO—In Case You Missed It: Recent Changes in Guidelines, New Publications and Conferences
The Art and Science of Prevention: Updates in HIV PrEP and Doxy-PEP
Welcome and Introductions
HIV Cure: Where Are We and Do We Have a Map?
Key Updates from CROI 2024
Managing Substance Use Disorders: Opioids, Stimulants, and Alcohol
Antiretroviral Therapy Cases From the Clinic(ians)
Sexually Transmitted Infections: Challenges in Management and Prevention
Reducing Cardiovascular Events in People With HIV: A Much-Needed REPRIEVE For an At-Risk Population
Hit Me With Your Best Shot! Routine Immunizations for People With HIV
Closing Remarks
(March 26, 2024) Latest Update on Urgent Virus Outbreaks: March 2024
Welcome and Introductions
From Data to Options: Advances in Sexually Transmitted Infection Prevention
Managing Substance Use Disorders: Opioids, Stimulants, and Alcohol
Key Updates from CROI 2024
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Statins in the Post–REPRIEVE Era: Who, When, and Why
Hypertension and Cardiometabolic Issues in People With HIV: 2024 Update
“Weighing In” on GLP-1 Receptor Agonists for People With HIV
LA Agents for HIV Therapeutics and Prevention: Where We Are, Where We Aren’t, & Where We’re Going
Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles Heel
Welcome and Introduction
Sex, Drugs, and ART: Addressing Substance Use in People with HIV
Preventing Heart Disease in People with HIV: Delivering REPRIEVE from a Major Comorbidity
“Weighing In” on GLP-1 Receptor Agonists for People With HIV
Updates in STI Prevention and Treatment: DoxyPEP and More
The Future of ART
Closing
State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIV
State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention
Annoying But Necessary: Navigating the Challenges of LA Treatment & Prevention Strategies
Welcome and Introduction
Closing Remarks
Challenging Cases in LA Treatment and Prevention: What Would You Do?
(October 19, 2023) Latest Update on Urgent Virus Outbreaks: October 2023
(August 1, 2023) Latest Update On Urgent Virus Outbreaks August 2023
Welcome and Introductions
Patient Perspective: Long COVID
Pathogenesis of Long COVID: Organicity and Mechanisms
Long COVID Diagnosis and Management: A Case-Based Panel Discussion
Long COVID and HIV
Long COVID Clinical Trials: Challenges and Opportunities
Closing
(June 15, 2023) A Conversation About Dispatches From the AIDS Pandemic: A Public Health Story
Welcome and Introduction
New and Investigational Antiretroviral Drugs and Formulations
In Case You Missed It: CROI 2023, Publications, and Guidelines
Challenging Cases in Antiretroviral Therapy and Panel Discussion
The Latest Updates on HIV Prevention
Treatment and Management of Syphilis and Gonorrhea
Managing Cardiovascular Disease in People with HIV
Primary Care for People with HIV: Immunizations
(February 2, 2023) Latest Issues in COVID-19: Vaccines, Long COVID, Prevention, and Pediatrics
(Apri 20,2023) Latest Update on Urgent Virus Outbreaks: April 2023
Welcome and Introductoin
Key Updates from CROI 2023
New and Investigational Antiretroviral Drugs and Formulations
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Infant Feeding and People with HIV
Cardiovascular Disease and HIV
Managing Substance Use Disorders: Opioids, Stimulants, and Alcohol
Preexposure Prophylaxis
Managing Sexually Transmitted Infection: Doxycycline Postexposure Prophylaxis
Closing Remarks
New and Investigational Antiretroviral Drugs and New Strategies for HIV Management
Antiretroviral Therapy Cases From the Clinic(ians)
Managing Substance Use Disorders: Opioids, Stimulants, and Alcohol
Testing and Treating (and Preventing) Sexually Transmitted Infections in People With HIV
Latest Strategies in the Prevention of HIV
Long COVID: Diagnosis and Management
Closing
Welcome And Introduction
mRNA Vaccine Technology and the Prospects for an HIV Vaccine
Key Updated from CROI 2023
(March 21, 2023) Latest Update on Urgent Virus Outbreaks: March 2023
(January 9, 2023) Latest Update on Urgent Virus Outbreaks: COVID-19, RSV, and Influenza
Comorbidities In The Setting Of Antiretroviral Therapy
Recent Co-Infections In The Setting Of ART: MPX And COVID - 19
When And How To Switch
Substance Use Disorder
HIV Prevention And STI Screening And Prevention
Closing Remarks
Welcome And Introductions
When And What To Start
bNAbs: Where Are We Going?
In Case You Missed It: Updates From Recent Publications And Meetings
The Effect of the Pandemic on Ending the HIV Epidemic Initiative
Providing Gender Affirming Care
Closing Remarks
Welcome And Introductions
Antiretroviral Therapy Cases: HIV Prevention and Treatment
Anal Cancer Screening: What Now?
3.7.Closing
mRNA Vaccine Development for HIV Vaccines
New and Investigational Antiretroviral Drugs
Antiretroviral Therapy Cases From the Clinic(cians)
Providing Gender-Affirming Care
An Update on Hepatitis B Virus Infection
Management of AIDS-Related Opportunistic Infections
Methicillin-Resistant Straphylococcus aureus (MRSA) in PWH
Opioid Use Disorder
Urgent Emerging Infections in HIV: Monkeypox
Reducing Health Disparities Among Disparate Populations
Breast Feeding and Individuals With HIV
HIV Prevention From the Centers of Disease Control and Prevention Perspective
Current CDC STI Treatment Guidelines: An Update
HIV Practitioner Burnout Panel
(September 15, 2022) Continued Discussion on Urgent Virus Outbreaks: COVID-19, Monkeypox, and More
Aging And HIV
In Case You Missed It: The Latest in HIV Literature and Monkeypox
New And Investigational Drugs
Preexposure Prophylaxis
Recognizing And Managing Practitioner Burnout
Special Panel Session
Antiretroviral Therapy Cases From the Clinic(ians): A Case-Based Presentation and Panel Discussion
Welcome And Introductions
(August 23, 2022) Urgent Virus Outbreaks: COVID-19 and Monkeypox
Closing
Difficult Cases In Inpatient Care For COVID - 19
Difficult Cases In Prevention And Outpatient Care For COVID - 19
Post - COVID Complications
Roundtable Discussion
Welcome And Introductions
The Clinical Relationship Between HIV And COVID - 19
(July 7, 2022) COVID-19 Rebound, Subvariants BA.4 and BA.5, Vaccines, and More
Welcome And Introductions
The Revolution of MRNA Vaccines: Implications for an HIV Vaccine
CROI 2022 Review
New and Investigational Drugs for Treatment and Prevention
Challenges Cases in Antiretroviral Therapy and Panel Discussion
The Clinical Relationship Between HIV and COVID-19
Special Panel Session: 40 Years Later
(June 7, 2022) Detailed Discussion on COVID-19 Vaccines, Boosters, Therapeutics, Variants, and More
(May 6, 2022) COVID-19 Therapeutics, 2nd Booster, Variants of Variants, and COVID-19 in Children
Controversies In Managing Sexually Transmitted Infections: A Case-Based Panel Discussion
Frailty Screening Preventing And Intervening
Optimizing Preexposure Prophylaxis
Screening For Anal Cancer: When to Screen and What to Do With the Results
Welcome And Introductions
Special Panel 40 Years Later: Looking Back at the Beginning of the HIV/AIDS Epidemic in Atlanta, GA
(April 1, 2022) The Latest on Omicron Subvariant BA.2 in the US, 4th Dose, and Vaccine in Children
Antiretroviral Therapy Cases From the Clinic(ians): A Case-Based Presentation and Panel Discussion
In Case You Missed It: Updates From CROI 2022 and Beyond
(February 4, 2022) Latest Update on COVID-19 Vaccines and Scientific Leaders’ Perspectives
Welcome
Investigational Antiretroviral Drugs and Strategies
COVID-19 Interactions with Other Viruses
Current Options for Treating and Managing COVID-19
Updated CDC Guidelines on Testing and Treating Sexually Transmitted Infections
State-of-the-art Cases on Antiretroviral Therapy
In Case You Missed It: Updates From Recent Publications and Meetings
Expert Roundtable Discussion
(December 3, 2021) Omicron Variant, Therapeutics, and COVID-19 in People Who Are Immunocompromised
Welcome
PrEP: State of the Science Overview
Strategies to Optimize PrEP: Schedules, Formulations, and Innovative Approaches
Assessing and Monitoring Persons Interested in Starting and Continuing PrEP
Question-and Answer Panel Session
Ending the HIV Epidemic: The Impact of PrEP
How to Reach the Hard to Reach: Policies and Strategies to Address Access to PrEP
Leveraging Administrative and Governmental Policies to Improve PrEP Utilization
Expert Roundtable Discussion
Closing
(October 22, 2021) COVID-19 in People Who Are Immunocompromised, Waning Immunity, Breakthrough...
Assessing Frailty in Older People With HIV
Neurocognition and the Aging Brain
Cardiovascular Disease in HIV: Moving From Insights to Interventions
Identifying, Managing, and Preventing Polypharmacy in Older People With HIV
Primary Care Concerns for the Aging Population
Expert Roundtable Discussion
SARS-CoV-2 Variants: Where Did They Come From and Where Are They Going (June 18, 2021)
Up to Date on COVID-19: Expert Discussion (June 1, 2021)
Challenges and Opportunities in Providing Remote HIV, STI, and COVID-19 Testing and Services
Challenges and Opportunities for Preexposure Prophylaxis
Vaccine Prevention for Individuals With HIV in the Era of COVID-19
HIV and COVID-19: Impact on Susceptibility, Disease, and Long-term Complications
Preventing Severe COVID-19: The Role of Monoclonal Antibodies and Beyond
Panel Discussion
Update From vCROI 2021
Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion
Challenges and Opportunities for Preexposure Prophylaxis
Management and Prevention of Sexually Transmitted Infections
Immunology and Pathogenesis of COVID-19
Long COVID-19: Long-Term Complications of COVID-19
Current Antiretroviral Drugs and Strategies for HIV Management
Investigational Antiretroviral Drugs for HIV
Collateral Damage of COVID-19 onHIVPatient Care
Current Status of COVID-19 TreatmentOptions for Mild, Moderate, and Severe Disease
Aging and Frailty in People With HIV
Drug-Drug Interactions and Polypharmacyin HIV: Case-Based
HIV Stigma and Unreached Populations
Challenges and Success in PrEP Implementation
Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion
Long-Acting Antiretroviral Drug Formulations for Treatment and Preventionof HIV
Update on Early Treatment of COVID-19 (April 13, 2021)
Latest on “COVID-19 Meets HIV”: Variants, Vaccines, and Health Disparities (February 10, 2021)
Update on New Strategies for Antiretroviral Therapy
Challenges and Opportunities for Preexposure Prophylaxis
Aging and Frailty in People With HIV
Long COVID-19: The Long-Term Complications of COVID-19
Neurologic Complications of COVID-19
The Inexorable Advancement to Long-Acting Antiretrovirals: To Jupiter and Beyond!
Update on SARS-CoV-2 Variants, Vaccine Development, and Decreasing the Case Rate (January 29, 2021)
Update on COVID-19 Vaccines (January 4, 2021)
Impact of the COVID-19 on HCV and STIs (November 23, 2020)
Update From Our Nation’s Capital, ID Week, and OI Guidelines
PrEP in the Era of COVID-19: A Case-Based Discussion
Projected Health Policy Changes in 2021
Update on the Clinical Management of HIV: A Case-Based Discussion
Where We Stand Today on a SARS-CoV-2 Vaccine
Antiretroviral Therapy: When and What to Start
When and How to Switch ART Regimens
Ending the HIV Epidemic
Laboratory Monitoring in Individuals With HIV
Prevention of HIV Infection
COVID-19 Update: Including the Intersection of HIV
Aging and HIV: Polypharmacy, Frailty, and Neurocognition
Lessons From the Lab: Implications for Coronavirus Vaccine and Therapeutics (October 19, 2020)
Addressing Questions About COVID-19 (September 23, 2020)
HIV and COVID-19 Interactions and Parallels in Advocacy (September 15, 2020)
New Strategies and Challenges of PrEP in the COVID-19 Era (September 9, 2020)
Continued Discussion on COVID-19 Epidemiology and Transmission (August 19, 2020)
Investigational New Antiretroviral Drugs and Strategies
Interactive Antiretroviral Therapy Cases
COVID-19: Update on Therapy and Vaccine Research
Preexposure Prophylaxis: Cases and Common Questions
HIV and Opioid Use: The Intersection of the Co-Epidemics in the Midwest
Current Status of COVID-19 Treatment and Vaccine Research (July 31, 2020)
Insights From AIDS 2020/COVID-19 at IAS, Updates on COVID-19... (July 22, 2020)
Update From IAS 2020
Interactive Antiretroviral Cases From the Clinic(ians) and Panel Discussion
Multidimensional Challenge of COVID-19, Including COVId-19 and HIV
Preexposure Prophylaxis: Cases and Commom Questions
Why COVID-19 Will Not Mean the End of the STI Epidemic (and May Make It Worse)
COVID-19 Meets HIV: Focus on Health Disparities (June 30, 2020)
Common Preexposure Prophylaxis Questions: A Cased-Based Presentation
What's Known About the Intersection of COVID-19 and HIV Infection
The Current Status on Treatment and Vaccines
Controlling the Spread of Infectious Diseases: Best Practices
New Antiretroviral Drugs and Strategies
Interactive Antiretroviral Therapy Cases and Panel Discussion
COVID-19 in Women (June 17, 2020)
COVID-19 Public Health Updates (June 10, 2020)
Ending the HIV Epidemic: Reaching the Unsuppressed and Out of Care Panel Discussion
Cardiovascular Diseases in HIV
Inflammation and Its Role in HIV Pathogenesis and Aging
Fri - Horn
Renal Disease and Kidney Transplant
Common PrEP Questions: A Case-Based Discussion
Neurocognitive Disorders in HIV
Ending the HIV Epidemic: Reaching the Unsuppressed and Out of Care Panel Discussion
Sexually Transmitted Infections on the Rise: Syphilis, Chlamydia, and Gonorrhea
Antiretroviral Therapy and Pregnancy in 2019: Current Recommendations and Controversies
Opioid Use and Substance Abuse Disorder
HRSA's HIV/AIDS Bureau Updates
Investigational Approaches to Antiretroviral Therapy
Treating HIV in 2019: Interactive Cases From the Clinic(ians) and Panel Discussion
Best Practices in HIV Care: Providing Gender Affirming Care for Transgender and Nonbinary People
Initiating Antiretroviral Therapy: What to Start and How to Monitor
Fundamentals of Antiretroviral Therapy
Sexual Health in Adolescents
Immunoprotection in HIV and Sexually Transmitted Infections
Sexually Transmitted Infections: The National Perspective
Sexually Transmitted Infections: The Local Perspective
Antiretroviral Therapy (ART) in Conception and Pregnancy in Women With HIV
Interactive Case-Based Panel Discussion: PrEP, STIs, and Sexual Health
Preexposure Prophylaxis: Current State of the Art
Syphilis: Reemergence of the Great Pretender?
Aging With HIV: I’ve Fallen But I Can Get Back Up
HIV Cure: Fact or Fiction
CROI 2019 Update on Tuberculosis and Other Opportunistic Infections
Investigational Approaches to Antiretroviral Therapy
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
The Data-Free Zone: Tough Cases in HIV Prevention and STI Management
Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion
Sexually Transmitted Infections: Burning Issues
Infectious and Other Complications of Immunobiologic Agents Used by Individuals With HIV Infection
Update From the 2019 Conference on Retroviruses and Opportunistic Infections
Investigational Approaches to Antiretroviral Therapy
Interactive ART Case-Based Panel Discussion
Be Prepped for PrEP: Case-Based Discussion and PrEP in the Future
Is Hepatitis B Curable?
Addiction And HIV In 2019 What You Need To Know To Care For Your Patient
Chronic Pain In People Living With HIV Infection A Practical, Evidence - Based Approach
Immune Reconstitution Inflammatory Syndrome (IRIS) In HIV Infection Beyond What Meets The Eye
New Antiretroviral Strategies And Drugs
Sexually Transmitted Infections Cases From The Clinic(ians)
Treating And Preventing HIV In 2019 Interactive Cases From The Clinic(ians)
What’s New In Opportunistic Infections And…Washington DC
Addiction and HIV in 2019: What You Need to Know to Care for Your Patients
Top 10 Updates in Viral Hepatitis for the HIV Practitioner
Common PrEP Questions: A Case-Based Panel Discussion
Interactive ART Cases From the Clinic: Is There One Right Answer?
New Drugs and Novel Strategies for Antiretroviral Therapy
Update From CROI 2019: Ending AIDS by 2030
Infectious and Other Complications of Immunobiologic Agents Used by Individuals With HIV Infection
Advances Toward A Cure For HIV Getting Beyond N = 1 2
Common PrEP Questions A Case - Based Discussion
HIV And Liver Disease
Interactive ART Cases From The Clinic(ians) Case - Based Panel Discussion
New Drugs In Development Are We Ready For Long - Acting ART
Sexually Transmitted Infections
Management Of Comorbidities In Older Adults With HIV Infection
ART In Women And Pregnancy InSTIs, Comorbid Conditions, And Other Current Issues
Interactive PrEP Cases And Discussion
Interactive ART Cases From The Clinic(ians) Case - Based Panel Discussion
Update From The 2019 Conference On Retroviruses And Opportunistic Infections
Therapeutic HIV Vaccines and Broadly Neutralizing Antibodies
HIV Disease Management Course Overview
Audience Cases and Discussion: “I have a patient who…”
Cases: Treatment of and Monitoring for Hepatitis C in Patients with Cirrhosis
Cases: Management of Hepatitis C in Prior Treatment Failure
Cases: Issues in Hepatitis C in Active or Recently Active Substance Abuse and Renal Failure
Cases: Initial Treatment of Hepatitis C
Management of Liver Diseases: A Nonhepatologist’s Viewpoint
Hepatitis C: Introduction and Overview
Overview of Hepatitis C in South Carolina
Welcome and Participant Introductions
Audience Cases and Discussion: “I have a patient who…”
Cases: Treatment of Hepatitis C in Patients with Cirrhosis and Advanced Liver Disease
Cases: Management of Hepatitis C in Prior Treatment Failure
Cases: Initial Treatment of Hepatitis C
Hepatology for the Nonhepatologist
Hepatitis C in 2018: From Evolution to Revolution
Welcome and Participant Introductions
Audience Cases and Discussion: “I have a patient who…..”
Cases: Treatment of Hepatitis C in Patients with Cirrhosis and Advanced Liver Disease
Cases Management Of Hepatitis C In Prior Treatment Failure
Cases: Issues in Hepatitis C in Active or Recently Active Substance Abuse and Renal Failure
Cases: Initial Hepatitis C Treatment, Including Coinfection
Hepatology for the Nonhepatologist
Hepatitis C in 2018: From Evolution to Revolution
Welcome, Introductions, and Overview
Cases: Treatment of and Monitoring for Hepatitis C in Patients with Cirrhosis
Cases: Management of Hepatitis C in Prior Treatment Failure
Cases: Initial Treatment of Hepatitis C: Key Populations
Cases: Treatment of Hepatitis C in HIV/HCV Coinfection
Cases: Initial Treatment of Hepatitis C
Hepatology for the Nonhepatologist
Viva La Revolución: Options to Combat Hepatitis C
HIV, Hepatitis C, and Opioid Abuse: A Tennessee Tale
Welcome and Participant Introductions
Audience Cases and Discussion: “I have a patient who…”
Cases: Post-SVR Care and Monitoring
Cases: Management of HCV in Prior Treatment Failure
Cases: Initial Treatment of the Hepatitis C Virus-Infected Patient
End-Stage Liver Disease (ESLD): A Guide for HIV Physicians
Hepatitis C Introduction and Overview
Welcome, Introductions, and Overview
Opioid Withdrawal, Opioid Substitution, and HIV Infection
HIV and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Implications
New Advances in HIV Prevention and Sexual Health
Microbes in the Middle: Understanding How the Human Microbiome Interacts with HIV
Antiretroviral Therapy – Cases From the Clinic (ians): Interactive Case-Based Panel Discussion
Investigational Approaches to Antiretroviral Therapy: New Strategies and Novel Agents
CROI 2018: What You Need to Know
Infectious and Other Complications of Immunobiologic Agents Used by HIV-Infected Individuals
Welcome to the IAS–USA Annual Update on HIV Disease Management
Top 10 Updates in Liver Care for the HIV Provider
Transgender Health and HIV Infection
Primary Care of the HIV-Infected Adult: If I Can Do It, You Can Do It
Antiretroviral Therapy (ART) Strategies: Interactive Case-Based Panel Discussion
Going With Your Gut: The Microbiome and You